von Elm, E., D. G. Altman, M. Egger, S. J. Pocock, P. C. Gøtzsche, J. P. Vandenbroucke, and the Strobe Initiative. 2007. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies. Annals of Internal Medicine 147(8):573-577.
West, S., V. King, T. Carey, K. Lohr, N. McCoy, S. Sutton, and L. Lux. 2002. Systems to rate the strength of scientific evidence. Evidence Report/Technology Assessment No. 47. (Prepared by the Research Triangle Institute-University of North Carolina Evidence-based Practice Center under Contract No. 290-97-0011.) AHRQ Publication No. 02-E016. Rockville, MD: Agency for Healthcare Research and Quality.
Whiting, P., A. W. Rutjes, J. Dinnes, J. B. Reitsma, P. M. Bossuyt, and J. Kleijnen. 2005. A systematic review finds that diagnostic reviews fail to incorporate quality despite available tools. Journal of Clinical Epidemiology 58:1-12.
Wieland, S., and K. Dickersin. 2005. Selective exposure reporting and Medline indexing limited the search sensitivity for observational studies of the adverse effects of oral contraceptives. Journal of Clinical Epidemiology 58(6):560-567.
Wilczynski, N. L., D. Morgan, R. B. Haynes, and the Hedges Team. 2005. An overview of the design and methods for retrieving high-quality studies for clinical care. BMC Medical Informatics and Decision Making 5(20).
Wilensky, G. R. 2006. Developing a center for comparative effectiveness information. Health Affairs w572.
World Health Organization. 2007. International clinical trials registry platform http://www.who.int/ictrp/en/ (accessed August 9, 2007).
Yusuf, S., R. Peto, J. Lewis, R. Collins, and P. Sleight. 1985. Beta blockade during and after myocardial infarction: An overview of the randomized trials. Progress in Cardiovascular Diseases 27(5):335-371.